Source: European Journal of Pharmacology. Unidade: FOB
Subjects: CÉLULAS ESTROMAIS, HIPERTENSÃO, MEDULA ÓSSEA DE ANIMAL, RATOS, OSTEOGÊNESE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRITO, Victor Gustavo Balera et al. Telmisartan impairs the in vitro osteogenic differentiation of mesenchymal stromal cells from spontaneously hypertensive male rats. European Journal of Pharmacology, v. 912, p. 10 , 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2021.174609. Acesso em: 06 nov. 2024.APA
Brito, V. G. B., Patrocinio, M. S., Barreto, A. E. A., Frasnelli, S. C. T., Lara, V. S., Santos, C. F. dos, & Oliveira, S. H. P. de. (2021). Telmisartan impairs the in vitro osteogenic differentiation of mesenchymal stromal cells from spontaneously hypertensive male rats. European Journal of Pharmacology, 912, 10 . doi:10.1016/j.ejphar.2021.174609NLM
Brito VGB, Patrocinio MS, Barreto AEA, Frasnelli SCT, Lara VS, Santos CF dos, Oliveira SHP de. Telmisartan impairs the in vitro osteogenic differentiation of mesenchymal stromal cells from spontaneously hypertensive male rats [Internet]. European Journal of Pharmacology. 2021 ; 912 10 .[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.ejphar.2021.174609Vancouver
Brito VGB, Patrocinio MS, Barreto AEA, Frasnelli SCT, Lara VS, Santos CF dos, Oliveira SHP de. Telmisartan impairs the in vitro osteogenic differentiation of mesenchymal stromal cells from spontaneously hypertensive male rats [Internet]. European Journal of Pharmacology. 2021 ; 912 10 .[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.ejphar.2021.174609